Introduction
Oxygen free radicals as well as other high-energy oxygen containing molecules, collectively referred to as reactive oxygen species (ROS), have been shown to participate in a diverse number of important phenomena associated with human diseases including cancer (Oberley and Buettner, 1979; Cerutti, 1985) , neurodegeneration (Floyd, 1999) and aging (Ames et al., 1993) . It has been well-established that ROS involve in cellular transformation, tumor promotion and progression. Chinese hamster cells and V79 cells exposed to superoxide generated from xanthine/xanthine oxidase or other chemicals resulted in chromosome aberration (Iwata et al., 1984; Sofuni and Ishidate, 1984) . Tumor promoter agents, such as phorbol 12-myristate 13-acetate (PMA) and dimethyl benzanthracene (DMBA), increased tumor initiation and promotion by increasing cellular production of ROS (Giri et al., 1999; Jaruga et al., 1994; Emerit and Cerutti, 1981) . In addition, the tumor promoter agents and ROS synergistically increased cell transformation in vitro and in vivo (Kennedy et al., 1984; Zimmerman and Cerutti, 1984; Nakamura et al., 1985) . On the other hand, the level of antioxidant enzymes that decrease ROS is generally lower in cancer cells than that of normal parental cells (Oberley and Buettner, 1979) . Tumor promoter activity can be prevented or reduced by antioxidant systems (Yan et al., 1996; Liu et al., 1997) . Taken together, these data have suggested that there is a causal relationship between the enhanced production of ROS and cell transformation, tumor promotion and progression.
Despite the convincing evidence for the involvement of ROS in carcinogensis, the intracellular signaling by which ROS mediate oncogenic transformation and tumor progression remains largely unknown. A growing body of evidence has suggested that ROS participate in intracellular signal transduction to regulate gene expression and modulate cellular activity (Alder et al., 1999) . A variety of extracellular stimuli, such as receptor ligations, transiently increase intracellular production of ROS (Thannickal et al., 1998; Liu et al., 2000; Sundaresan et al., 1995) . Scavenging the increased production of ROS has been shown to inhibit receptor-mediated signaling and gene activation (Bae et al., 2000; Thannickal et al., 1998; Liu et al., 2000; Sundaresan et al., 1995) . More recently, superoxide has been demonstrated to cascade ras oncogenic signaling and has been implicated in cell transformation and tumor promotion (Irani et al., 1997; Yang et al., 1999) . Re-introduction of superoxide dismutase gene or antioxidants in cancer cell lines can reverse the tumor phenotype and reduce tumor malignancy, suggesting that superoxide and other ROS participate in the carcinogenesis and tumor malignancy (Zhong et al., 1997; Li et al., 1998 Li et al., , 2000 Pani et al., 2000) . However, because superoxide is produced in many biochemical pathways in all aerobic cells, the speci®c function of superoxide involved in oncogenic signaling leading to tumor malignancy has not been well de®ned. Ampli®cation of wild-type ras gene or mutation of ras gene contributes to a large proportion of human cancer. In this study, we set out to investigate the functional role of superoxide in tumor malignancy by overexpression of H-ras gene in SV-40 transformed WI-38 VA-13 human lung model cells. We con®rmed that the stable expression of active H-ras dramatically increased cellular production of superoxide in part through the activation of membrane NADPH oxidase. Furthermore, we showed the increased production of superoxide serves as an intracellular messenger relaying the H-ras signal, stimulating cell proliferation and migration, and enhancing cell resistance to TNF-a treatment.
Results
Expression of active H-ras stimulated WI-38 VA-13 cell proliferation and migration Ampli®cation and mutations of H-ras contribute to a large percentage of human cancer and lead to uncontrolled cell growth, proliferation and metastasis. In this investigation, we used the SV-40 transformed human lung cells as a model system to study the cellular processes of active H-ras on tumor malignancy. The SV-40 transformed human lung WI-38 VA-13 cells (passages between 265 and 285) have a relatively slow rate of cell proliferation with the doubling time at 32+3 h ( Figure 1b and data not shown). Cells grown in 0.4% agar for 3 weeks did not form colonies greater than 2 mm in diameter. Transplanted 2610 5 cells in 0.1 ml medium to the¯ank regions of 3 ± 4 week old athymic nude mice (Harlan Sprague Dawley Inc.) did not form a measurable size of solid tumor in 1 month (data not shown). These data indicated that the SV-40 transformed WI-38 VA-13 cells have a relatively less malignant phenotype in vitro and in vivo. Under this background, we have introduced wild type H-ras (WT-H-ras) and mutant H-ras (V12-H-ras) genes into the WI-38 VA-13 cells respectively by transfection. Following selection by G418 at the concentration of 1.2 mg/ ml for 3 weeks, cell clones were analysed for the expression of H-ras. For convenient comparison, parental cells, one vector control cell clone, one WT-H-ras clone and one V12-H-ras clone were chosen for further study in this investigation. As shown in Figure  1a , H-ras expression is dramatically increased in WT-H-ras and V12-H-ras transfected cells compared to parental and vector control transfected cells by Western analysis. The expression of WT-H-ras modestly, while expression of V12-H-ras signi®cantly, increased cell proliferation ( Figure 1b ) and migration ( Figure 1c ). The increased cell proliferation and migration can be reduced by the transient expression of dominant negative N17-H-ras (data not shown), suggesting that the expression of WT-H-ras or V12-Hras contributes to the increased cell proliferation and migration. Figure 1 Overexpression of active H-ras gene on WI-38VA-13 cell proliferation and migration. (a) Western analysis of H-ras protein in parental, vector control, WT-H-ras and V12-H-ras transfected cell clones. SV-40 transformed human lung WI-38VA-13 cells were transfected with vector alone, vector containing WT-H-ras, and V12-H-ras respectively. Cells were then selected in the presence of 1.2 mg/ml of G418 for 3 weeks as described in the context. A total of 20 mg cellular protein was separated on 15% SDS ± PAGE gel, transferred to PVDF membrane, immunoreacted with anti-H-ras and anti-b-actin antibody and detected by ECL. (b) Eect of expression of active H-ras on cell proliferation. Parental and transfected cells (2610 4 ) were plated on 6-well plates in triplicate and cultured in complete medium for 24, 48, and 72 h respectively. Cell number was counted with a hemocytometer at each time point after trypsinizing. Cell proliferation was plotted as fold-increase in cell number (number of cells at each time point divided by number of cells seeded). All *P, **P values were less than 0.05 vs parental controls (n=3 in each group of experiments). (c) Eect of expression of active Hras on cell migration. A 24-trans-well plate with 0.4 mm pore size was used to measure cell migration. Parental and transfected cells (1610 6 ) were plated on the top of the trans-well in triplicate and cultured in complete medium for 6, 12, and 18 h respectively. Cells passed through and stayed on the bottom side of the transwells were collected and counted with a hemocytometer at each time point. Cell migration was expressed as a percentage (number of cells migrated at each time point divided by total number of cells seeded). All *P, **P values were less than 0.05 vs parental controls (n=3 in each group of experiments) Oncogene Superoxide enhances cell proliferation, migration and resistance to TNF-a R Liu et al Expression of active H-ras increased intracellular superoxide production in SV-40 transformed human lung WI-38VA13 cells
Expression of H-ras has been shown to increase intracellular production of superoxide in NIH3T3 cells (Irani et al., 1997) and human keratinocyte HaCaT cells (Yang et al., 1999) . For this reason, we measured the intracellular superoxide production using a cytochrome c reduction method described previously (Pick, 1986) . Figure 2 showed a time-dependent accumulation of superoxide production in WI-38VA13 cells. Expression of WT-H-ras modestly, while expression of V12-H-ras signi®cantly increased intracellular superoxide production. The increased superoxide production could be blocked by the dominant negative N17-H-ras (data not shown), suggesting that the increased superoxide results from the expression of WT-H-ras or V12-H-ras speci®cally.
Intracellular superoxide production by expression of active H-ras is attenuated by protein kinase inhibitor genistein and dominant negative N17-Rac1
Enhanced superoxide production appears to participate in H-ras signal transduction pathway that modulates oncogenic processes. However, the mechanism resulting in the activation of intracellular superoxide production remains largely unknown. Treatment of WI-38VA-13 cells with a general protein tyrosine kinase inhibitor, genistein at 30 mM (Figure 3a ), but not PI3-kinase inhibitor LY294002 at 50 mM (Figure 3a) , or wortmannin at 50 nM (data not shown), dramatically reduced the superoxide production induced by expression of active V12-H-ras (Figure 3a) . Incubation of cells overexpressing active H-ras with genistein from 5 ± 50 mM produced a dose-dependent decrease of superoxide production (data not shown), indicating that protein tyrosine kinase activity is required for superoxide production by active H-ras.
Rac1 has been demonstrated to participate in cell transformation (Qiu et al., 1995) and NADPH oxidasemediated superoxide production (Sundaresan et al., 1995; Diekmann et al., 1994; Freeman et al., 1996) .
Thus, a dominant negative N17-Rac1 was used to study the H-ras-mediated superoxide production. Transient transfection of N17-Rac1 signi®cantly reduced superoxide production in the cells overexpressing active H-ras gene (Figure 3b ), suggesting that intracellular superoxide production by active H-ras is mediated through the rac1/NADPH oxidase pathway.
Intracellular superoxide production by expression of active H-ras is decreased by diphenylene iodonium (DPI) or apocynin, but not by rotenone, allopurinol or oxypurinol
Enhanced intracellular superoxide production could be derived from the oxidation chain reactions in mitochondria, xanthine oxidase activity in cytosol, or NADPH oxidase activity in the plasma membrane. Figure 2 Superoxide production in parental, vector control, WT-H-ras and V12-H-ras transfected cell clones. Superoxide was measured as described in Materials and methods. The accumulative production of superoxide were expressed as nMoles/2610 5 cells. All *P, **P, ***P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments) Figure 3 Enhanced superoxide production by active-H-ras is dependent on protein tyrosine kinase and active Rac1. (a) Eects of protein kinase or PI3-kinase on superoxide production by Hras. Total 2610 5 parental, vector control, WT-H-ras or V12-Hras transfected cells were pretreated with 50 mM of genistein or 50 mM of LY294002 respectively for 4 h. Cells were then washed twice with sterile PBS and incubated with 160 mM of cytochrome c for 2 h. Superoxide assay was carried out as described in Materials and methods. All *P, **P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments). (b) Eect of Rac1 on superoxide production by active H-ras. Cells were transiently transfected either control vector or dominant negative Rac1 (N17-Rac) plasmid DNA as described in Materials and methods. After transfection, cells were recovered at room temperature for 30 min. Cell viability was determined by Trypan blue exclusion assay. Total 2610 5 viable cells were plated in each well and grown overnight. Superoxide assay was carried out as described in Materials and methods. All *P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments) Cells pretreated with 30 mM of DPI, a NADPH oxidase inhibitor, reduced superoxide production. In contrast, treatment with 50 mM rotenone, a mitochondrial oxidase inhibitor (Figure 4a ), 100 mM allopurinol or 50 mM oxypurinol, inhibitors of xanthine oxidase, produces no signi®cant eects ( Figure 4B ). These results suggest that NADPH oxidase is primarily involved in the superoxide production by active H-ras eect. The increased superoxide production by NADPH oxidase was further con®rmed by a structurally unrelated NADPH oxidase inhibitor, 50 mM apocynin (Figure 4c ). Taken together, these results demonstrated that the activation of NADPH oxidase activity by the expression of H-ras contributes to the intracellular superoxide production.
Intracellular superoxide production by expression of active H-ras stimulated WI-38 VA-13 cell proliferation and migration
Because overexpression of active H-ras also increased WI-38VA-13 cell proliferation and migration, a superoxide-dependent oncogenic activity by active H-ras was investigated. Pre-treating cells with PEG-SOD (200 units/ml) which scavenges superoxide, but not PEG-Catalase (300 units/ml) which scavenges hydrogen peroxide, decreased active H-ras mediated cell proliferation ( Figure 5a ) and migration ( Figure 6a ). The inhibition of active H-ras-mediated mitogenic activity by PEG-SOD, but not PEG-Catalase, was con®rmed by [ Figure 6 ). In contrast, treatment of cells with rotenone, a mitochondrial oxidase inhibitor, or allpurinol and oxypurinol, xanthine oxidase inhibitors did not have a signi®cant eect on cell proliferation and migration (data not shown). These results demonstrated that active H-ras-mediated superoxide from NADPH oxidase contributes to the cell proliferation and migration.
Intracellular superoxide production by expression of active H-ras enhanced WI-38 VA-13 cell resistance to TNF-a treatment
Mutations of H-ras oncogene lead to uncontrolled cell growth and proliferation. In many cases, the malignant tumor cells become resistant to radiation and drug therapy. We hypothesize that the intracellular production of superoxide by active H-ras may also act as a cell death-resistant signal for malignant tumor cell survival. For this reason, WI-38VA-13 cells transfected with vector control, WT-H-ras and V12-H-ras genes respectively were used to test the susceptibility of cells to cytotoxic cytokine, TNF-a treatment. Incubation of cells with TNF-a resulted in a dose-dependent increase in cell death as measured by trypan blue exclusion ( Figure 7a ) and MTT assay (data not shown). Overexpression of active V12-H-ras gene signi®cantly increased cell resistance to TNF-a compared to that of vector control, while overexpression of WT-H-ras had a modest eect. Pre-treatment of cells expressing V12-H-ras with dominant negative N17-H-ras, dominant negative N17-Rac1, PEG-SOD, and DPI, all of which reduce H-ras-mediated superoxide production, increased cell sensitivity to TNF-a treatment ( Figure   Figure 4 Eects of mitochondria oxidase, NADPH oxidase and xanthine oxidase inhibitors on intracellular superoxide production by active H-ras. (a) Eect of mitochondria oxidase inhibitor, rotenone, and NADPH oxidase inhibitor, DPI, on cell production of superoxide by active H-ras. Cells were either untreated or pretreated with 50 mM rotenone or 30 mM DPI for 4 h. Then, cells were exposed to 160 mM cytochrome c for 2 h and superoxide assay was carried out as described in Materials and methods. All *P, **P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments). (b) Eects of xanthine oxidase inhibitors on superoxide production by H-ras. Same as (a) except cells were either untreated or pretreated with 100 mM allopurinol or 50 mM oxypurinol, inhibitors of xanthine oxidase. All ***P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments). (c) Eect of a NADPH oxidase inhibitor, apocynin, on cell production of superoxide by active H-ras. Same as (a) except cells were either untreated or pretreated with 50 mM of apocynin, a structurally unrelated NADPH inhibitor. All *P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments) Oncogene Superoxide enhances cell proliferation, migration and resistance to TNF-a R Liu et al 7b). In contrast, PEG-Catalase or rotenone, which do not aect H-ras-mediated superoxide production, did not have signi®cant eect on cell sensitivity to TNF-a treatment ( Figure 7b ). Similar results were obtained in ionizing radiation treated WI-38 VA-13 cells (unpublished result) . Taken together, these results demonstrated that the active H-ras-mediated superoxide production provides a survival signal for tumor malignancy.
Discussion
In this report, we demonstrated that the expression of H-ras, especially the constitutively active V12-H-ras in SV-40 transformed human lung WI-38 VA-13 cells increases intracellular superoxide production. The activation of NADPH oxidase-like activity by active H-ras contributes to the production of superoxide that subsequently enhances cell proliferation, migration and resistance to TNF-a treatment. To our knowledge, this is the ®rst evidence to demonstrate that superoxide serves as a ras eector to modulate cell proliferation, migration and cell sensitivity to cytokine treatment in association with tumor malignancy. Previous studies by Irani et al. (1997) in NIH3T3 cells and Yang et al. (1999) in human keratinocyte HaCaT cells demonstrated that increased superoxide production activated cell proliferation. Our results con®rmed the mitogenic role of superoxide in cell proliferation and further parental, vector alone, WT-H-ras or V12-H-ras transfected cells were either untreated or pre-treated with 200 units/ml PEG-SOD, 300 units/ml PEG-Catalase were added to the top wells and allowed to migrate for 12 h. Cells which migrated to the bottom chamber and stayed on the bottom were harvested and counted. All *P, **P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments). (b) Eects of rotenone or DPI on cell migration. Same as in (a) except cells were either untreated or pretreated with 50 mM rotenone or 30 mM DPI. All *P, **P values were less than 0.05 vs speci®c parental controls (n=3 in each group of experiments)
showed the H-ras-mediated superoxide production enhances cell migration and resistance to TNF-a treatment.
Superoxide participates in Ras signal relay to modulate tumor cell malignancy Superoxide and its derivative ROS have been conventionally regarded as carcinogenic agents and have been demonstrated to participate in tumor initiation, promotion and progression (Cerutti, 1985; Iwata et al., 1984; Nakamura et al., 1985) . Generally, tumor cells produced more ROS than that of normal control cells because of the low expression of antioxidant enzymes (Oberley and Buettner, 1979; Cerutti, 1985; Yan et al., 1996) . However, because all oxygen-consuming cells produce basal levels of superoxide from several biochemical pathways in dierent cell compartments, the functional role of superoxide in modulating tumor cell malignancy has not been clearly de®ned. In addition, because the half-life of superoxide is short and the chemical reaction is fast, its role in intracellular signal transduction remains largely unknown. Expression of active V12-H-ras produced a signi®cant amount of superoxide in NIH3T3 cells and human keratinocyte HaCaT cells, resulting in increased cell proliferation (Irani et al., 1997; Yang et al., 1999) . To better study the potential role of superoxide and other ROS in the ras oncogenic signal transduction leading to tumor malignancy, we chose SV-40 transformed human lung WI-38 VA-13 cell line for its low endogenous H-ras expression (Figure 1a) , relatively slow growth rate with a doubling time at 32+3 h ( Figure 1b) and relatively less tumor malignancy in vitro and in vivo in term of anchorage-dependent growth and tumor generation in nude mice (data not shown). We used the stable transfection approach to investigate the functional role of superoxide in tumor biology. Like NIH3T3 ®broblast cells and human keratinocyte HaCaT cells, overexpression of active H-ras signi®cantly increased superoxide production in WI-38 VA-13 cells (Figure 2 ). Because superoxide can be automatically or enzymatically dismutated to hydrogen peroxide, and both superoxide and hydrogen peroxide have been reported to be transiently increased by many extracellular stimuli, we have utilized PEG-SOD and PEG-Catalase to dierentiate the speci®c ROS species mediating the Ras eect. Cells treated with PEG-SOD which dismutates superoxide to hydrogen peroxide, had dramatically reduced proliferation and migration, while those treated with PEG-Catalase, which converts hydrogen peroxide to water and oxygen, did not have a signi®cant eect, suggesting superoxide primarily participates in the Ras signal relay in promoting cell proliferation and migration ( Figures 3, 4 and 5 ).
It appears that the enhanced superoxide production in the WT-H-ras and V12-H-ras overexpressing clones are protein tyrosine kinase dependent and PI3-Kinase independent, because pre-incubating cells with genistein, a general protein tyrosine kinase inhibitor, but not LY294002 or wortmannin, the PI3-K inhibitors, decreased superoxide production (Figure 3a) . The phosphorylation events leading to superoxide production by H-ras activation are not known. Ras activation has been shown to activate multiple MAP kinases in mammalian cells, some of which, for example, ERK1 and ERK2 subsequently translocate into the nucleus and modulate transcriptional activity for cell proliferation (Brunet and Pouyssenur, 1996) . The direct contribution of MAP kinases to WI-38 VA-13 cell proliferation and migration by expression of active Hras appears not to be signi®cant, because blocking the increased superoxide production dramatically reduced cell proliferation and migration (Figures 5 and 6 ). The relationships between MAP kinases and NADPH oxidase have not been established. More recently, Ward et al., (2000) demonstrated that p38 MAP kinase activity contributed to NADPH oxidase-mediated respiratory burst upon TNF-a and LPS priming in neutrophil cells. It is likely that MAP kinases activated by active H-ras may modulate NADPH oxidase activity for superoxide production that subsequently stimulates cell proliferation and migration (Figure 8 ). Eects of active H-ras-mediated superoxide on cell survival upon TNF-a treatment. (a) Dose-dependent decrease of cell viability by TNF-a treatment. Vector control, WT-H-ras and V12-H-ras transfected cells were treated with dierent doses of TNF-a for 12 h. Cells were then processed for viability analysis by trypan blue exclusion. All *P values were less than 0.05 vs speci®c vector transfection controls (n=3 in each group of experiments). (b) Eects of dominant negative H-ras, dominant negative rac1, PEG-SOD, PEG-catalase, rotenone and DPI on cell viability upon TNF-a treatment. Vector control and V12-Hras expressing cells were either untreated or transfected with dominant negative H-ras, dominant negative rac1 or treated with PEG-SOD, PEG-catalase, Rotenone and DPI respectively. Cells were exposed to 200 ng/ml of TNF-a for 12 h. Cells were then processed for viability analysis by Trypan blue exclusion assay. All *P values were less than 0.05 vs speci®c vector transfection controls (n=3 in each group of experiments)
On the other hand, we demonstrated that Rac1 was required for the production of superoxide, because a dominant negative N17-rac1 could block the enhanced superoxide production by active H-Ras eect in WI-38 VA-13 cells. Regulation of superoxide and ROS generation by Rac1 has also been observed in NIH3T3 cells and human keratinocyte HaCaT cells (Irani et al., 1997; Yang et al., 1999) . More importantly, Rac1 has been demonstrated to interact with NADPH oxidase subunit (Diekmann et al., 1994; Freeman et al., 1996) . Thus, it is likely that expression of active H-ras may activate Rac1 that subsequently stimulates the assembly of NADPH oxidase on plasma membrane to enhance superoxide production in human lung WI-38 VA-13 cells (Figure 8 ).
Activation of NADPH oxidase contributes to the elevation of superoxide production that subsequently enhances cell proliferation, migration and resistance to TNF-a treatment Superoxide production has been demonstrated in a variety of cellular compartments and dierent biochemical pathways. Oxidation of oxygen molecules in mitochondria produces a certain amount of superoxide depending on cell types and activation status (Loschen et al., 1974) . Xanthine oxidase activation contributes signi®cantly to the cytoplasmic superoxide production (Fridovich, 1983) . In addition, NADPH oxidase in phagocytic cells produces a large amount of superoxide in immune responses (Pretone et al., 1980) . Using speci®c inhibitors, we have established that overexpression of active H-ras in WI-38 VA-13 cells activated superoxide production from NADPH oxidase activity. Furthermore, we demonstrated that the NADPH oxidase-mediated superoxide production stimulated WI-38 VA-13 cell proliferation and migration in the active H-ras expressing cells.
The phagocytic NADPH oxidase is a multicomponent enzyme complex located in the plasma membrane. The assembly and activation of NADPH oxidase activity is mediated by Rac1, which triggers and stabilizes the clustering of a multi-protein complex (Quinn, 1995; Dagher et al., 1995) . In the presence of cofactors and regulators, the NADPH oxidase catalyzes one electron reduction of oxygen to superoxide (Irani and Goldchmidt-Clermont, 1998) . It has been shown by several groups that the NADPH oxidase, or NADPH oxidase-like activity exists in non-phagocytic cells, including ®broblasts (Irani et al., 1997; Jones et al., 1994) , endothelial cells (Jones et al., 1996) and keratinocyte cells (Yang et al., 1999) . The elevated superoxide production in WI-38 VA-13 cells expressing active H-ras was primarily derived from the NADPH oxidase activity, because superoxide production can be inhibited by DPI or apocynin, but not rotenone, allopurinol or oxypurinol (Figure 4) .
The NADPH oxidase-mediated superoxide production in WI-38 VA-13 cells overexpressing active H-ras stimulated cell proliferation ( Figure 5 ) and migration ( Figure 6 ). After pre-incubation of cells with PEG-SOD, not PEG-Catalase, there was a signi®cant decrease in cell proliferation and migration by active H-ras eect (Figures 5 and 6 ), suggesting that superoxide, not hydrogen peroxide, participates in the relay of H-ras eect in WI-38 VA-13 cells. The function of active H-ras-mediated superoxide in stimulating cell proliferation in WI-38 cell VA-13 cells is consistent with previous observations in NIH3T3 cells (Irani et al., 1997) , and human keratinocyte HaCaT cells (Yang et al., 1999) . The function of superoxide in cell migration is most likely due to the activation of cytoskeletal organization. Crawford et al. (1996) demonstrated actin polymerization was concurrent with increased superoxide production in post-hypoxic endothelial cells. Moreover, endothelial cell migration in the wound was signi®cantly retarded in the presence of DPI or MnSOD mimetic (Moldovan et al., 2000) . Activation of Rac has been shown to participate in actin polymerization and cell proliferation, suggesting that Rac-mediated superoxide production may contribute, at least partially, to cell proliferation and migration (Qiu et al., 1995; Joneson et al., 1996) . More recently, it has been demonstrated that activation of Rac1 generated ROS and subsequently altered cytoarchitecture in rabbit synovial ®broblasts (Kheradmand et al., 1998) . Based on our observation as well as previous evidence in other cells, we concluded that activation of NADPH oxidase activity by active H-ras contributed to the production of superoxide, which subsequently stimulated cell proliferation and migration in WI-38 VA-13 cells. Because increased oxidative activity is frequently associated with tumor malignancy, we further utilized a well-de®ned TNF-a cytotoxic system to investigate the role of H-ras-mediated superoxide production in tumor cell survival. Expression of active H-ras signi®cantly increased cell resistance to TNF-a treatment (Figure 7) . Upon blocking active H-ras-mediated superoxide generation, or scavenging superoxide production, cell sensitivity to TNF-a treatment was increased, suggesting that superoxide acts as a death-resistant signal to promote tumor cell survival and malignancy. Study by Clement and Stamenkovi (1996) in a variety of cancer cell lines demonstrated that cellular superoxide is a natural inhibitor of Fas-mediated cell death. However, the eects of superoxide on cellular activity appear to depend on the dose, cell type, cellular antioxidant/ antioxidant enzyme status and source of superoxide generation. Because of the chemical nature, superoxide and ROS, at a high concentration, often causes cell toxicity (Zhai et al., 2000; Hildeman et al., 1999) . Increasing of mitochondrial superoxide production by decreasing MnSOD expression or inhibition of MnSOD activity triggers cytochrome c release and consequently results in apoptotic cell death (Atlante et al., 2000; Huang et al., 2000) . Alteration of intracellular level of ROS by expression of active ras alone can induce human primary ®broblast senescence (Lee et al., 1999) . However, by simultaneous expression of V12-Rac1 with V12-H-ras, cell proliferation was enhanced (Lee et al., 1999) . These data demonstrated the importance of dose and location of superoxide and ROS generation on cellular activity.
Because a prooxidant state is a common feature of cancer cells, elevated superoxide may render the cancer malignant phenotype. The contribution of NADPH oxidase to the generation of superoxide in cancer biology remains largely unknown. The data presented in this report demonstrated that the active H-ras-mediated superoxide production by NADPH oxidase cascades ras oncogenic activity and modulates cell proliferation, migration and sensitivity to TNF-a treatment.
Superoxide and other ROS serve as general intracellular messengers to cascade intracellular signal and modulate cell activity A variety of extracellular stimuli including cytokines, such as TNF-a Bohler et al., 2000) , TGF-b1 (Thannickal et al., 1998; Ohba et al., 1994) , IL-1 (Meier et al., 1989; Kather, 1995a) and interferon-g (Krieger-Brauer and Kather, 1995a) , peptide growth factors, such as PDGF (Sundaresan et al., 1995; Bae et al., 2000) , bFGF (Krieger-Brauer and Kather, 1995b) , EGF (KriegerBrauer and Kather, 1995b) and insulin (Kamata et al., 1996) , can stimulate cellular ROS production. The transiently increased ROS is functionally associated with gene regulation and various cellular activity, including cell growth, proliferation and dierentiation. Human oral carcinoma SCC-25 cells treated with TNF-a increased superoxide production which induced MnSOD gene expression . Hydrogen peroxide was also detected in primary culture of mesangial cells upon exposure to TNF-a or IL-1 a, which subsequently initiated an apoptotic cell death (Bohler et al., 2000) . Ligation of PDGF with its receptor in rat vascular smooth muscle cells activated the generation of hydrogen peroxide which stimulated DNA synthesis and chemotaxis (Sundaresan et al., 1995) . PC12 cells treated with NGF increased oxygen free radicals that promoted neuronal dierentiation. Upon scavenging these ROS, neuronal dierentiation was signi®cantly reduced even in the presence of NGF (Kamata et al., 1996) . Taken together, it appears that ROS serve as intracellular messengers modulating cell growth, dierentiation and gene expression upon extracellular stimulation or oncogenic activation. Superoxide and ROS serving secondary messengers for cellular function have distinct advantages because of their short half-life, transiently active, being easily synthesized and rapidly destroyed. The speci®c ROS molecules with dierent redox potentials may also serve as eectors of dierential receptors and oncogenic activity (Adler et al., 1999; Buettner, 1993) . That the superoxide cascaded the H-ras oncogenic signal and promoted tumor malignancy suggest that an antioxidative therapy combined with speci®c drug and/or radiation therapy may provide an eective approach to prevent tumor progression.
Materials and methods

Chemicals and reagents
Genistein, wortmannin, LY294002 were purchased from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Recombinant human TNF-a, rotenone, diphenylene iodonium (DPI), apocynin, allopurinol, oxypurinol and other chemicals were purchased from Sigma Chemicals (St. Louis, MO, USA). Genistein, wortmannin and LY294002 were dissolved in dimethylsulfoxide (DMSO). Stock solutions were made at least 1006. A 1/100 dilution of DMSO in cell culture neither altered cell proliferation, viability, migration, nor aected superoxide measurements. Cell culture medium and transfection reagents were obtained from Life Technology Inc (Galesburg, MD, USA). Polyclonal antibody against H-ras or Rac1 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture
SV-40 transformed human lung WI-38 VA-13 cells (American Tissue Culture Collection, VA, USA) were grown in Dulbecco's modi®ed essential medium (DMEM) supplemented with 10% heat inactivated fetal bovine serum (FBS), 100 units/ml penicillin, 100 mg/ml streptomycin (DMEM complete medium). Cell culture medium was usually replaced every 3 ± 4 days. Once 90% con¯uence was reached, cells were dissociated with 0.25% Trypsin and 1 mM EDTA for 5 min. The disrupted cells were spun down and replated in new culture dishes or¯akes (Corning Inc., Acton, MA, USA).
H-ras cDNA and plasmid construction
The wild-type H-ras cDNA was cloned by RT ± PCR from human Jurkat cells. After DNA sequence con®rmation, the Oncogene Superoxide enhances cell proliferation, migration and resistance to TNF-a R Liu et al wild-type full-length cDNA was cloned into a pCMV-Myc mammalian expression vector driven by a CMV promoter (Clontech, Palo Alto, CA, USA). The constitutively active V12-H-ras was site-direct mutated based on the WT-H-ras cDNA template according to the manufacturer's instruction (Promega, Madison, WI, USA).
Transfection and selection
Stable transfection and selection were carried out essentially in the same way as previously described using a lipofectamine method (Liu et al., 1997) . Brie¯y, 5610 5 WI-38 VA13 cells were plated in 6 cm-diameter dishes (Corning Inc., Acton, MA, USA). Once 70 ± 80% con¯uence was reached, cells were washed twice with 16PBS, then cells were incubated with total 10 mg of plasmid DNA and 20 ml of lipofectamine (Gibco ± BRL) in a ®nal volume of 3.5 ml Opti-MEM. After 16 h of transfection, the mix was aspirated, and cells were cultured with DMEM medium with 15% FBS for an additional 12 h. Subsequently, cells were incubated with complete medium containing 1.2 mg/ml G418 for 3 weeks. Cell clones resistant to G418 were isolated and analysed. For convenience, parental, one vector control transfected, one WT-H-ras and one V12-H-ras transfected cell clone were selected for further studies. Transfected cells were routinely cultured in the presence of 1.2 mg/ml of G418. However, two days prior to and during the experiments, transfected cells were cultured in complete DMEM medium without G418.
For transient transfection, 20610 6 cells were incubated with 40 mg dominant negative H-ras (N17-H-ras) or dominant negative Rac1 (N17-Rac1) plasmid DNA in 0.5 ml Opt-MEM (Gibco ± BRL) at room temperature for 10 min, then cells were electroporated with a BTX electroporator using a low voltage mode at 220 V, 1 pulse, and 25 msec/V of pulse length. After electroporation, cells were kept at room temperature for 30 min and then cultured in complete medium. The transfection eciency as determined by using a green¯uorescent protein (GFP) construct (Clontech, Palo Alto, CA, USA) was usually about 70 ± 80% and cell viability determined by trypan blue exclusion was about 60%.
Superoxide measurement
Cytochrome c method was used to measure intracellular superoxide production according to previous descriptions (Pick, 1986) . Brie¯y, 2610 5 cells/well were seeded in 96-well at bottom plate and grown overnight. Cells were then washed twice in 16PBS twice and incubated with 100 ml/well of a 160 mM cytochrome c in phenol red-free Hanks' solution. For blank control, cells were incubated with cytochrome c containing 200 units/ml of polyethylene glycol coupled bovine erythrocyte superoxide dismutase (PEG-SOD) (Sigma Company, St. Louis, MO, USA). To minimize the peroxide eect on cytochrome c oxidation, 300 units/ml of polyethylene glycol coupled bovine catalase (PEG-Catalase) was included in the cell culture. For positive control, cells were incubated with 500 ng/ml of PMA. Cells were then incubated in 378C incubator for 1 h or de®ned time in experiments, and absorbency was measured on an ELISA reader at 550 nm.
The absorbency values were converted to nanomoles of superoxide based on the extinction co-ecient of cytochrome c (Pick, 1986) .
Cell proliferation assay
Parental, vector control, WT-H-ras and V12-H-ras transfected cells (2610 4 cells) were grown in 24 well plates and cultured in complete medium either in the presence or absence of 200 units/ml PEG-SOD or 300 units/ml PEGCatalase. The cell numbers were counted in triplicate at each time point using a hemocytometer after trypsinizing and plotted over time. The mitogenic eect of H-ras expression on human lung WI-38 VA-13 cells was measured by [ 3 H]Thymidine incorporation according to a previous method (Liu et al., 1998) . In brief, 2610 5 cells of parental, vector alone, WT-H-ras and V12-H-ras transfected cells were cultured in 24 well-plates in triplicate overnight. Cells were either untreated or pretreated with 200 units/ml PEG-SOD, 300 units/ml PEG-Cat, 50 mM Rotenone or 30 mM DPI for 4 h. Then cells were pulsed with 2.5 mci [ 3 H]Thymidine for 6 h. After washing with 16PBS twice, cells were lysed with 16PBS containing 0.2 N NaOH and 0.1% Triton X-100 and harvested onto glass ®ber ®lters. After washing three times with 3 ml 10% tricholoroacetic acid solution to remove free [ 3 H]Thymidine, the ®lters containing the labeled DNA were counted using a liquid scintillation counter and results were expressed in CPM or fold-increase in [ 
Cell migration assay
Twenty-four trans-well plates with 0.4 mm pore size (Costar, Cambridge, MA, USA) were used to measure cell migration. A total of 1610 6 parental, vector alone, WT-H-ras or V12-H-ras transfected cells were either untreated or pre-treated with 200 units/ml PEG-SOD, 300 units/ml PEG-Catalase, 50 mM rotenone, 30 mM DPI, 50 mM allopurinol, or 50 mM oxypurinol for 4 h was loaded to the upper chamber of the trans-well. Cells were then allowed to migrate at 378C for 12 h in the presence or absence of the treatment. Cells which migrated through and stayed on the bottom of trans-wells were harvested, combined together and counted with a hemocytometer. Percentage of cell migration was calculated as the number of cells migrated divided by the total number of cells applied to the top of the trans-wells.
Western analysis
Western analysis of the ras expression in parental, vector control, WT-H-ras or V12-H-ras transfected cells was carried out in a similar way to those described previously (Liu et al., 1999) . A total of about 5610 6 cells were washed with 16PBS twice and scraped o the dishes in the same solution. After centrifugation at 12 000 r.p.m. for 5 min, cell pellets were lysed vigorously in NP-40 lysis buer (50 mM Tris-HCl, pH 7.5, 150 mM, 0.5% NP-40, 1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin and 10 mg/ml aprotinin). Lysates were spun at 12 000 r.p.m. for 5 min at 48C. The protein concentrations in the supernatants were measured by Bradford method of Bio-Rad. A total of 10 mg of protein from each sample was separated on the 15% sodium dodecyl sulfate polyacrylamide gel (SDS ± PAGE), followed by transferring of separated proteins to a PVDF membrane and immunoreacted with anti-H-ras antibody. The immunoreactive protein was detected by enhanced chemiluminescence (ECL).
TNF-a treatment
Total 2610 5 cells/well were cultured in 24-well plate for 2 days in complete culture medium. Then cells in triplicate were treated with dierent doses of TNF-a for 12 h. Cells were then washed twice with 16PBS (pH 7.5) and cell viability was measured by Trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. 
Statistical analysis
